<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03081169</url>
  </required_header>
  <id_info>
    <org_study_id>209199</org_study_id>
    <nct_id>NCT03081169</nct_id>
  </id_info>
  <brief_title>Timing of VTE Prophylaxis in TBI</brief_title>
  <official_title>Timing of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loyola University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loyola University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the efficacy and complication rates of early (24 hours) versus late (72
      hours) VTE prophylaxis administration to TBI patients. Patients in both treatment groups will
      be monitored for development of VTE as well as complications from bleeding after commencement
      of VTE prophylaxis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This a randomized prospective study that compares the efficacy and complication rates of
      early (24 hours) versus late (72 hours) VTE prophylaxis administration to TBI patients.
      Patients who are identified as having an intracranial injury will be randomized to early
      versus late VTE prophylaxis using a 1:1 random numbers allocation. Patients in both treatment
      groups will be monitored for development of VTE, primarily with scheduled duplex ultrasound
      studies of the lower extremities. Any clinical suspicion of VTE will also be investigated
      with duplex ultrasound and/or CT angiogram of the chest. Patients will be monitored for
      development of complications from bleeding post commencement of VTE prophylaxis. Intracranial
      bleeding complications will be monitored by physical examination and CT scanning of the head
      when indicated. Patients who undergo craniotomy or craniectomy will have VTE prophylaxis
      started 72 hours post-surgery and will undergo CT scan of the head (to assure bleeding
      stabilization) prior to administration of VTE prophylaxis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2017</start_date>
  <completion_date type="Anticipated">February 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VTE</measure>
    <time_frame>Outcomes will be assessed until hospital discharge. Data will be presented at study completion with the expectation of approximately 2 years.</time_frame>
    <description>Venous thromboembolism (DVT or PE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding complications</measure>
    <time_frame>Outcomes will be assessed until hospital discharge. Data will be presented at study completion with the expectation of approximately 2 years.</time_frame>
    <description>Expanding intracranial hemorrhage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>TBI (Traumatic Brain Injury)</condition>
  <condition>VTE (Venous Thromboembolism)</condition>
  <arm_group>
    <arm_group_label>Early (24 hours)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive VTE prophylaxis (heparin 5000 U q 8 hrs or enoxaparin 30 mg q 12 hrs) 24 hours after injury if CT head is stable.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late (72 hours)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive VTE prophylaxis (heparin 5000 U q 8 hrs or enoxaparin 30 mg q 12 hrs) 72 hours after injury if CT head is stable.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enoxaparin Sodium 150 MG/ML Prefilled Syringe</intervention_name>
    <description>The same drugs and dosages will be used in both groups, with only the timing being different</description>
    <arm_group_label>Early (24 hours)</arm_group_label>
    <arm_group_label>Late (72 hours)</arm_group_label>
    <other_name>Lovenox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <description>The same drugs and dosages will be used in both groups, with only the timing being different</description>
    <arm_group_label>Early (24 hours)</arm_group_label>
    <arm_group_label>Late (72 hours)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Traumatic brain injury

          -  Intracranial hemorrhage on CT scan

        Exclusion Criteria:

          -  Under the age of 18

          -  Pregnant

          -  Die within 24 hours of admission

          -  Hospital stay less than 5 days

          -  Contraindications to enoxaparin or heparin

          -  Coagulopathy at 24 hours post-injury defined as INR&gt;1.6 aPTT&gt;2x normal, or platelet
             counts&lt;50k

          -  Known history of VTE
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Anstadt, MD</last_name>
    <phone>708-327-2072</phone>
    <email>manstadt@lumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Gonzalez, MD</last_name>
    <phone>708-327-2072</phone>
    <email>richard.gonzalez@lumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Anstadt, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Anstadt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2017</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loyola University</investigator_affiliation>
    <investigator_full_name>Michael Anstadt</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Enoxaparin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

